{"id":244114,"date":"2026-09-16T21:05:28","date_gmt":"2026-09-17T02:05:28","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/09\/cancer-drug-pushes-mutant-blood-stem-cells-to-become-short-lived-immune-cells"},"modified":"2026-09-16T21:05:28","modified_gmt":"2026-09-17T02:05:28","slug":"cancer-drug-pushes-mutant-blood-stem-cells-to-become-short-lived-immune-cells","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/09\/cancer-drug-pushes-mutant-blood-stem-cells-to-become-short-lived-immune-cells","title":{"rendered":"Cancer drug pushes mutant blood stem cells to become short-lived immune cells"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/cancer-drug-pushes-mutant-blood-stem-cells-to-become-short-lived-immune-cells.jpg\"><\/a><\/p>\n<p>The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators. Because the broad activity of interferon-alpha can induce significant side effects, developing more focused strategies based on these mechanistic findings could meet an important need in cancer therapy.<\/p>\n<p>Myeloproliferative neoplasms arise when DNA mutations in blood stem cells lead to the excess production of specific types of blood cells, such as megakaryocytes, which make platelets. Interferon-alpha often helps patients by reducing these imbalances and depleting the pool of mutant blood cells.<\/p>\n<p>In the study, <a href=\"https:\/\/www.nature.com\/articles\/s41588-026-02751-3\" target=\"_blank\">published<\/a> in <i>Nature Genetics<\/i>, the investigators used advanced single-cell profiling tools to discover how interferon-alpha exerts these effects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators. Because the broad activity of interferon-alpha can induce significant side effects, developing more focused strategies based on these mechanistic findings could [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-244114","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=244114"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244114\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=244114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=244114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=244114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}